心包积液预测COVID-19患者临床结局:一项全国性多中心研究
该回顾性多中心研究纳入1197例COVID-19患者,分析胸部CT心包积液与30天死亡率、机械通气和ICU入住的关系。心包积液患病率13.3%,其存在与30天死亡率独立相关(多因素HR=1.60),且仅在男性患者中有预测作用,女性患者中无预测作用。
要点
- COVID-19患者心包积液患病率为13.3%。
- 心包积液存在是男性患者30天死亡率的独立预测因子(多因素HR=1.60)。
- 女性患者中心包积液各项指标均不能预测临床结局。
核心结论
- 心包积液在COVID-19中患病率为13.3%,是男性患者30天死亡率的独立预测因子,在女性患者中无预测作用。
研究设计与样本
- 回顾性研究,德国多中心项目RACOON的一部分,纳入1197例患者(女性363例,占30.3%;男性834例,占69.7%),每例均分析胸部CT心包积液,收集30天死亡率、机械通气需求和ICU入住需求数据,采用描述性统计、Mann-Whitney检验、Fisher精确检验及单因素和多因素回归分析。
诊断标准与关键数值
- 心包积液存在与30天死亡率相关:单因素分析HR=1.54,95%CI(1.05; 2.23),p=0.02;多因素分析HR=1.60,95%CI(1.03; 2.48),p=0.03;男性患者多因素分析HR=1.56,95%CI(1.01-2.43),p=0.04;心包积液密度与插管需求相关:单因素OR=1.02,95%CI(1.003; 1.05),p=0.03;与ICU入住需求相关:单因素OR=1.03,95%CI(1.005; 1.05),p=0.01。
临床应用与阅片要点
- 在COVID-19患者胸部CT阅片时,应关注并报告心包积液及其密度,因其可能提示男性患者30天死亡风险升高。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: The prognostic role of pericardial effusion (PE) in Covid 19 is unclear. The aim of the present study was to estimate the prognostic role of PE in patients with Covid 19 in a large multicentre setting.
MATERIALS AND METHODS: This retrospective study is a part of the German multicenter project RACOON (Radiological Cooperative Network of the Covid 19 pandemic). The acquired sample comprises 1197 patients, 363 (30.3%) women and 834 (69.7%) men. In every case, chest computed tomography was analyzed for PE. Data about 30-day mortality, need for mechanical ventilation and need for intensive care unit (ICU) admission were collected. Data were evaluated by means of descriptive statistics. Group differences were calculated with Mann-Whitney test and Fisher exact test. Uni-and multivariable regression analyses were performed.
RESULTS: Overall, 46.4% of the patients were admitted to ICU, mechanical lung ventilation was performed in 26.6% and 30-day mortality was 24%. PE was identified in 159 patients (13.3%). The presence of PE was associated with 30-day mortality: HR= 1.54, CI 95% (1.05; 2.23), p = 0.02 (univariable analysis), and HR= 1.60, CI 95% (1.03; 2.48), p = 0.03 (multivariable analysis). Furthermore, density of PE was associated with the need for intubation (OR=1.02, CI 95% (1.003; 1.05), p = 0.03) and the need for ICU admission (OR=1.03, CI 95% (1.005; 1.05), p = 0.01) in univariable regression analysis. The presence of PE was associated with 30-day mortality in male patients, HR= 1.56, CI 95%(1.01-2.43), p = 0.04 (multivariable analysis). In female patients, none of PE values predicted clinical outcomes.
CONCLUSION: The prevalence of PE in Covid 19 is 13.3%. PE is an independent predictor of 30-day mortality in male patients with Covid 19. In female patients, PE plays no predictive role.
引用
- Bucher AM, Henzel K, Meyer HJ, et al. Pericardial Effusion Predicts Clinical Outcomes in Patients with COVID-19: A Nationwide Multicenter Study. Acad Radiol. 2023. PMID: 38155024. doi:10.1016/j.acra.2023.12.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。